From: Association between EGF +61 G/A and glioma risk in a Chinese population
Variable | Patients (n = 677) No.(%) | Controls (n = 698) No.(%) | P value* |
---|---|---|---|
Gender | Â | Â | 0.141 |
   Male | 400(59.1) | 384(55.0) |  |
   Female | 277(40.9) | 314(45.0) |  |
Age(years) | Â | Â | 0.355 |
   Children(≤18) | 69(10.2) | 60(8.6) |  |
   Adults(>18) | 608(89.8) | 638(91.4) |  |
Smoking statusa | Â | Â | 0.093 |
   Never | 386(65.8) | 454(65.3) |  |
   Ever | 72(12.3) | 111(16.0) |  |
   Current | 129(22.0) | 130(18.7) |  |
Family history of cancer | Â | Â | 0.056 |
   No | 566(83.6) | 609(87.2) |  |
   Yes | 111(16.4) | 89(12.8) |  |
Histology | Â | Â | Â |
   Astrocytomasb | 256(37.8) |  |  |
   Glioblastoma | 220(32.5) |  |  |
   Other gliomasc | 201(29.7) |  |  |
WHO | Â | Â | Â |
   WHOI | 61(9.0) |  |  |
   WHOII | 236(34.9) |  |  |
   WHOIII | 118(17.4) |  |  |
   WHOIV | 262(38.7) |  |  |